• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Turns Higher; Anavex Life Sciences Shares Plunge

    1/2/24 12:15:29 PM ET
    $AVXL
    $CORT
    $LBPH
    $LMDX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AVXL alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday.

    The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500 also fell, dropping, 0.45% to 4,748.51.

    Check This Out: How To Earn $500 A Month From Annaly Capital Management Stock

     

    Leading and Lagging Sectors

     

    Energy shares rose by 1.5% on Tuesday.

    In trading on Tuesday, information technology shares fell by 2.2%.

     

    Top Headline

     

    Rivian Automotive Inc (NASDAQ:RIVN) reported vehicle production and delivery totals for the fourth quarter.

    The company produced 17,541 vehicles (vs. 10,020) at its manufacturing facility in Normal, Illinois, and delivered 13,972 cars in the fourth quarter. The latest-quarter delivery was below the third-quarter figure of 15,564 and below analysts' estimate of 14,430, as per Reuters.

     

    Equities Trading UP

     

    Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) shares shot up 194% to $17.70 after the company announced topline data from the PACIFIC Study evaluating bexicaserin in patients with Developmental and Epileptic Encephalopathies.

    Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) got a boost, surging 25% to $10.54 after the company announced a strategic collaboration and capsid license agreement with Novartis to advance potential gene therapies for Huntington's disease and spinal muscular atrophy.

    SenesTech, Inc. (NASDAQ:SNES) shares were also up, gaining 35% to $1.7099 after the company announced the expansion of its distribution agreement with Pesterminators to include the deployment of Evolve and extend its territory into the UAE.

     

    Equities Trading DOWN

     

    Anavex Life Sciences Corp. (NASDAQ:AVXL) shares dropped 33% to $6.25 after the company provided an update on Rett Syndrome program.

    Shares of LumiraDx Limited (NASDAQ:LMDX) were down 26% to $0.0475. LumiraDx agreed to sell its point-of-care technology platform to Roche.

    Corcept Therapeutics Incorporated (NASDAQ:CORT) was down, falling 26% to $23.97 after the company announced the Court for the District of New Jersey issued a decision that Teva Pharmaceuticals does not infringe any asserted claims of Corcept's U.S. Patents 10,195,214 and 10,842,800.

    Also Check This Out: Top 4 Tech And Telecom Stocks That May Fall Off A Cliff In Q4

     

    Commodities

     

    In commodity news, oil traded down 1.5% to $70.56 while gold traded up 0.1% at $2,073.80.

    Silver traded down 0.2% to $24.035 on Tuesday while copper fell 0.6% to $3.8685.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 fell 0.16%, London’s FTSE 100 fell 0.28% while Spain’s IBEX 35 Index rose 0.78% The German DAX rose 0.09% French CAC 40 fell 0.26% while Italy’s FTSE MIB Index rose 0.57%.

    Bank lending to households in the Eurozone increased by 0.5% year-over-year to EUR 6.87 trillion in November. The HCOB Eurozone manufacturing PMI rose to 44.4 in December, from the preliminary level of 44.2.

    The S&P Global UK manufacturing PMI was revised lower to 46.2 in December from the preliminary estimate of 46.4, while German manufacturing PMI was revised higher to 43.3 in December versus a preliminary reading of 43.1. The HCOB France manufacturing PMI declined to 42.1 in December versus 42.9 a month ago.

     

    Asia Pacific Markets

     

    Asian markets closed lower on Tuesday, with Hong Kong’s Hang Seng Index falling 1.52% and China’s Shanghai Composite Index falling 0.43%. India’s S&P BSE Sensex, meanwhile, fell 0.53%.

    The official NBS non-manufacturing PMI for China rose to 50.4 in December from November's reading of 50.2, while manufacturing PMI fell to 49.0 in from 49.4. Singapore’s GDP increased by 2.8% year-over-year in the fourth quarter versus a revised 1.0% increase in the third quarter. The Judo Bank Australia manufacturing PMI fell to 47.6 in December versus a preliminary reading of 47.8.

     

    Economics

     

    The S&P Global manufacturing PMI was revised lower to 47.9 in December versus a preliminary level of 48.2, and versus November’s level of 49.4.

    Now Read This: Accenture, Lyft And 2 Other Stocks Insiders Are Selling

    Get the next $AVXL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVXL
    $CORT
    $LBPH
    $LMDX

    CompanyDatePrice TargetRatingAnalyst
    Rivian Automotive Inc.
    $RIVN
    4/1/2026$14.00Underperform → Neutral
    DA Davidson
    Corcept Therapeutics Incorporated
    $CORT
    3/26/2026Underperform → Peer Perform
    Wolfe Research
    Rivian Automotive Inc.
    $RIVN
    3/10/2026$20.00Hold → Buy
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    3/4/2026$14.00Underperform
    BofA Securities
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    Rivian Automotive Inc.
    $RIVN
    1/14/2026$15.00Neutral → Sell
    UBS
    More analyst ratings

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rivian Automotive upgraded by DA Davidson with a new price target

    DA Davidson upgraded Rivian Automotive from Underperform to Neutral and set a new price target of $14.00

    4/1/26 9:04:14 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Corcept Therapeutics upgraded by Wolfe Research

    Wolfe Research upgraded Corcept Therapeutics from Underperform to Peer Perform

    3/26/26 8:53:32 AM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rivian Automotive upgraded by TD Cowen with a new price target

    TD Cowen upgraded Rivian Automotive from Hold to Buy and set a new price target of $20.00

    3/10/26 8:38:01 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026

    Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present new data from its pivotal Phase 3 ROSELLA trial of Lifyorli™ (relacorilant) plus nab-paclitaxel in platinum-resistant ovarian cancer at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The data will be presented in an oral presentation on Friday, May 29, 2026. Overall survival subgroup analyses for prior taxane use in the phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel versus nab-paclitaxe

    4/21/26 1:09:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rivian and Redwood Materials Announce Energy Storage Partnership for Manufacturing

    Largest repurposed battery energy storage system for a U.S. automotive manufacturer to cut energy costs, support grid reliability. American automotive and technology company Rivian (NASDAQ:RIVN) and critical materials and energy technology company Redwood Materials today announced a partnership to deploy pioneering battery energy storage at Rivian's Normal, Illinois manufacturing facility. Using more than 100 second-life Rivian battery packs, Redwood and Rivian's solution will initially provide 10 megawatt-hours (MWh) of dispatchable energy to reduce cost and grid load during peak demand periods—saving on cost and supporting grid security and reliability. Rivian will provide EV battery

    4/14/26 12:00:00 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mcdonough Claire sold $184,410 worth of shares (10,245 units at $18.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 946,814 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    4/24/26 4:43:40 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Director Wilson James N gifted 2,000 shares (SEC Form 4)

    4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)

    4/24/26 4:30:08 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Gomez Aidan N.

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    4/22/26 4:43:02 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $AVXL
    $CORT
    $LBPH
    $LMDX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Corcept Therapeutics Incorporated

    SCHEDULE 13G/A - CORCEPT THERAPEUTICS INC (0001088856) (Subject)

    4/21/26 4:20:37 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Voyager Therapeutics Inc. filed SEC Form 8-K: Leadership Update

    8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)

    4/21/26 4:05:48 PM ET
    $VYGR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Corcept Therapeutics Incorporated

    DEF 14A - CORCEPT THERAPEUTICS INC (0001088856) (Filer)

    4/17/26 4:08:18 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Director Flatley Jay T bought $25,281 worth of shares (1,830 units at $13.81) and sold $11,775 worth of shares (580 units at $20.30), increasing direct ownership by 0.78% to 162,070 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    3/5/26 5:10:12 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Financials

    Live finance-specific insights

    View All

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rivian Releases Q1 2026 Production and Delivery Figures and Sets Date for First Quarter 2026 Financial Results

    Rivian Automotive, Inc. (NASDAQ:RIVN) today announced production and delivery totals for the quarter ending March 31, 2026. The company produced 10,236 vehicles at its manufacturing facility in Normal, Illinois and delivered 10,365 vehicles during the same period. Production and delivery results for the quarter are in line with Rivian's outlook. Rivian is also reaffirming its 2026 delivery range guidance of 62,000 to 67,000 vehicles. The company also announced that on April 30, 2026, after market close, it will release its first quarter 2026 financial results. Rivian will host an audio webcast at 5:00 p.m. ET the same day to discuss the performance and outlook for the business. The live

    4/2/26 8:30:00 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Leadership Updates

    Live Leadership Updates

    View All

    Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report

    GJB2-GT (SENS-601) CTA/IND-enabling studies progress, supported by regulatory interactions with FDA and EMA since Q3 2025, and on track for CTA submission in H1 2026 SENS-501 Audiogene trial ongoing; six-month efficacy data expected in Q1 2026 Strengthened balance sheet and shareholder registry via €60m financing in January 2026, including a €20m strategic investment from Sanofi; cash runway extended to end of H1 2027 Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today reported its full-year 2025 results, provided a corp

    3/18/26 2:30:00 AM ET
    $LBPH
    $ARNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Dr. Axel Paeger, MD, MBA, MBI to its Board of Directors. "We are delighted to welcome Dr. Paeger to our Board of Directors at Anavex," said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. "Dr. Paeger brings three decades of strong leade

    2/23/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AVXL
    $CORT
    $LBPH
    $LMDX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Voyager Therapeutics Inc.

    SC 13G/A - Voyager Therapeutics, Inc. (0001640266) (Subject)

    11/14/24 6:13:11 PM ET
    $VYGR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care